Millipore Sigma Vibrant Logo

324380 Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem

324380
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
25316-40-9C₂₇H₂₉NO₁₁ · HCl

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
324380-10MG
Récupération des données relatives à la disponibilité...
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Ampoule plast. 10 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      Demander le prix
      Description
      OverviewAntitumor antibiotic and a highly effective myotoxin that inhibits topoisomerase II (IC50 = 100 nM). Binds to nucleic acids, presumably by specific intercalation into the DNA double helix, thereby inhibiting nucleic acid synthesis. Induces apoptosis in rhabdomyosarcoma cell lines. Also available as a 10 mM solution in H2O (Cat. No. 504042).
      Catalogue Number324380
      Brand Family Calbiochem®
      SynonymsAdriamycin, 14-Hydroxydaunomycin, HCl
      References
      ReferencesA'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.
      Product Information
      CAS number25316-40-9
      ATP CompetitiveN
      FormOrange to red powder
      Hill FormulaC₂₇H₂₉NO₁₁ · HCl
      Chemical formulaC₂₇H₂₉NO₁₁ · HCl
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targettopoisomerase 2
      Primary Target IC<sub>50</sub>100 nM
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSQI9295900
      Safety Information
      R PhraseR: 45-46

      May cause cancer.
      May cause heritable genetic damage.
      S PhraseS: 36/37-45-53-22-28

      Wear suitable protective clothing and gloves.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Avoid exposure - obtain special instructions before use.
      Do not breathe dust.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C. Under acidic conditions doxorubicin is converted to a water-insoluble adriamycinone and a water soluble reducing sugar, daunosamine.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      324380

      Références bibliographiques

      Aperçu de la référence bibliographique
      A'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.

      Brochure

      Titre
      Tools and Tips for Analyzing Apoptosis
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-May-2018 JSW
      SynonymsAdriamycin, 14-Hydroxydaunomycin, HCl
      DescriptionAn anti-tumor antibiotic and a highly effective myotoxin that inhibits topoisomerase II (IC50 = 100 nM). Binds to nucleic acids, presumably by specific intercalation into the DNA double helix, inhibiting nucleic acid synthesis. Cytotoxicity seems to be due to its ability to intercalate with DNA, interact with plasma membranes, and take part in oxidation-reduction reactions. Induces apoptosis in rhabdomyosarcoma cell lines.
      FormOrange to red powder
      CAS number25316-40-9
      RTECSQI9295900
      Chemical formulaC₂₇H₂₉NO₁₁ · HCl
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (10 mg/ml)
      Storage +15°C to +30°C
      Hygroscopic
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C. Under acidic conditions doxorubicin is converted to a water-insoluble adriamycinone and a water soluble reducing sugar, daunosamine.
      Toxicity Carcinogenic / Teratogenic
      Merck USA index14, 3439
      ReferencesA'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.